AbelZeta is a global clinical-stage biopharmaceutical company with centers of excellence in Rockville, Maryland and Shanghai, China. AbelZeta is focusing on developing innovative and proprietary cell-based therapeutic products and is committed to ushering in bespoke treatments that harness the body's own immune system to fight against hematological malignancies and solid tumors, as well as inflammatory and immunological diseases. AbelZeta advances research and development in its own GMP facilities at its centers of excellence for early-stage clinical studies, with a pipeline comprised of CAR-T and TIL therapies.
Company Details
- Employees
- 130
- Founded
- -
- Address
- 9605 Medical Center Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.abelzeta.com
- Keywords
- Biopharmaceutical, Biotechnology, Research & Development, Manufacturing, Cell Therapy, Innovation, Immuno-Oncology, I & I.
- HQ
- Rockville, Maryland
Abelzeta Questions
Abelzeta's website is https://www.abelzeta.com
Abelzeta's LinkedIn profile is https://www.linkedin.com/company/abelzeta
Abelzeta has
130 employees.
View email and phone details for 130
employees at Abelzeta.
Abelzeta's industry is
Biotechnology Research
Abelzeta's top competitors are
Neogene Therapeutics,
Novavax,
Regenxbio,
Milliporesigma,
Astrazeneca,
Arcellx,
Kite Pharma,
Gracell Biotechnologies,
Cellectis,
Gsk.
Abelzeta's categories are Biotechnology Research
Abelzeta's founding year is 2009
